Health
EU regulator probes possible kidney damage from coronavirus drug – Macau Business
The EU’s medicines regulator said Friday it is investigating reports of possible “acute” kidney damage in patients taking the coronavirus drug remdesivir
The EU’s medicines regulator said Friday it is investigating reports of possible “acute” kidney damage in patients taking the coronavirus drug remdesivir, made by US pharma giant Gilead.
The European Medicines Agency recommended the use of the anti-viral drug, sold under the brand name Veklury, in June after studies showed it could reduce the length of hospital stays for Covid-19 sufferers.
“EMA’s safety committee has started a review… to assess reports of acute kidney injury in some patients …
-
Noosa News19 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
General22 hours agoTrial of celebrity crocodile wrangler Matt Wright to hear from more witnesses
-
Noosa News17 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
Noosa News21 hours agoWhy the Story Bridge won’t have a traffic lane repurposed for bikes and walkers